Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma | MicrobiomeTrials← Back to trialsNCT05284643
Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2022-09-30Est. Completion: 2027-09-30
Enrollment target: 96 participants Locations- University of Miami, Miami, Florida, United States
Other microbiome trials you might be interested in
Glioblastoma Multiforme (GBM)Pancreatic Ductal Adenocarcinoma (PDAC)
The goal of this Phase I clinical trial is to evaluate how the imaging drug 203Pb- RMX-VH-PIB distributes in the body an…
Houston, United StatesEst. completion Dec 31, 2026
High Grade GliomaGlioblastoma Multiforme
This is a study of DSP-0390 in patients with recurrent high grade glioma.
San Francisco, United StatesEst. completion Sep 30, 2027